Investigation of trimethoprim-sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting

Letter/Communication

T M Harris, A C Bowen, D C Holt, Derek S Sarovich, K Stevens, B J Currie, B P Howden, J R Carapetis, P M Giffard and S Y C Tong

Clinical Microbiology and Infection, Vol.24(9), pp.1027-1029

2018

Files and links (1)

url

https://doi.org/10.1016/j.cmi.2018.04.020View

Published Version

staphylococcus aureus

trimethoprim

sulfamethoxazole

cotrimoxazole

resistance

methicillin-resistant

S. aureus

No abstract available.

Title: Investigation of trimethoprim-sulfamethoxazole resistance in an emerging sequence type 5 methicillin-resistant Staphylococcus aureus clone reveals discrepant resistance reporting
Authors: T M Harris (Author) - Menzies School of Health Research
A C Bowen (Author) - University of Western Australia
D C Holt (Author) - Charles Darwin University
Derek S Sarovich (Author) - University of the Sunshine Coast - Faculty of Science, Health, Education and Engineering
K Stevens (Author) - University of Melbourne
B J Currie (Author) - Menzies School of Health Research
B P Howden (Author) - University of Melbourne
J R Carapetis (Author) - University of Western Australia
P M Giffard (Author) - Charles Darwin University
S Y C Tong (Author) - University of Melbourne
Publication details: Clinical Microbiology and Infection, Vol.24(9), pp.1027-1029
Publisher: Elsevier Ltd.
Date published: 2018
DOI: 10.1016/j.cmi.2018.04.020
ISSN: 1198-743X
Organisation Unit: University of the Sunshine Coast, Queensland; Centre for Bioinnovation
Language: English
Record Identifier: 99451347702621
Output Type: Letter/Communication

865 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

This output has contributed to the advancement of the following goals:

Source: InCites